Coming up soon, Copenhagen will be the center of health economics as more than five thousand pharmaceutical and healthcare professionals gather for the ISPOR conference. ISPOR has been well known, especially among health economists. However, this years’ top trends real-world data (RWD) and real-world evidence (RWE) attract even wider audience.
Joining Medaffcon enables Dr. Johanna Simin to leverage her expertise to advance real-world data use and evidence-driven health. Medaffcon, in turn, can augment its in-house capabilities with the high-quality digital healthcare data found in Sweden.
Medaffcon has added Swedish healthcare registries to its capabilities as it continues to pursue growth and facilitate data utilisation by providing pharmaceutical companies access to rich and relevant healthcare data.
Single-arm research designs are challenging for a pharmaceutical reimbursement and marketing authorisation process.
Real World Evidence (RWE) ecosystem in Finland Real world data (RWD) is defined by FDA...
Medicines in Finland are divided into medicines in ambulatory and hospital care. This article describes...
The real world data (RWD) landscape in Finland offers globally unique data and possibilities to...
Pricing and reimbursement in Finland Pharmaceuticals Pricing Board (PPB), operating under the Ministry of Social...
Demonstrating that a health technology, e.g. a product, procedure or any intervention, is worth its...
Currently huge piles of health care data have been collected in Finland through national, regional...